Finance

Lists
Why is CARL up 2,63%?
Dive Deeper
CARL:NASDAQ
Carlsmed Inc
14,42 USD
+2,63%
(+0,37) 1D
14,42 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CARL...
Open
14,02 USD
High
14,58 USD
Low
14,00 USD
Mkt. cap
393,71 млн
Avg. vol.
90,86 миң
Volume
64,50 миң
52-wk high
17,23 USD
52-wk low
8,50 USD
EPS
-1,44 USD
Shares outstanding
27,30 млн
No. of employees
127
Open
14,02 USD
High
14,58 USD
Low
14,00 USD
Mkt. cap
393,71 млн
Avg. vol.
90,86 миң
Volume
64,50 миң
52-wk high
17,23 USD
52-wk low
8,50 USD
EPS
-1,44 USD
Shares outstanding
27,30 млн
No. of employees
127
News stories
From web sources and news partners
About Carlsmed Inc
CEO-
Employees127
Founded2018
HeadquartersКарлсбад, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websitecarlsmed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CARL in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CARL in the last 3 months.
Highest
Current 14,42 USD
23,00 USD (+59,50%)
Average
19,33 USD (+34,05%)
Lowest
17,00 USD (+17,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Newitter
Truist Financial
Buy
Reiterated
-
-
09/29/2026
Ryan Zimmerman
BTIG
Buy
Maintained
23,00 USD
+59,5%
09/28/2026
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
08/13/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
18,00 USD
+24,8%
08/06/2026
David Saxon
Needham
Buy
Reiterated
17,00 USD
+17,9%
08/06/2026
David Roman
Goldman Sachs
Buy
Maintained
16,00 USD
+11%
05/05/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
-0,39 USD / -0,40 USD
+1,27%beat
Revenue / Est. (USD)
18,94 млн / 17,80 млн
+6,40%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
13,07 млн
15,16 млн
16,12 млн
18,94 млн
Cost of goods sold
3,15 млн
3,56 млн
3,69 млн
4,40 млн
Cost of revenue
3,15 млн
3,56 млн
3,69 млн
4,40 млн
Research and development expenses
4,44 млн
5,26 млн
5,18 млн
6,04 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,52 млн
15,66 млн
16,52 млн
19,54 млн
Operating expense
18,96 млн
20,93 млн
21,70 млн
25,58 млн
Total operating expenses
22,11 млн
24,48 млн
25,39 млн
29,98 млн
Operating income
-9,04 млн
-9,32 млн
-9,28 млн
-11,04 млн
Other non operating income
-65,00 миң
7,00 миң
-
-
EBT including unusual items
-8,53 млн
-8,61 млн
-8,70 млн
-10,51 млн
EBT excluding unusual items
-8,53 млн
-8,61 млн
-8,70 млн
-10,51 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,53 млн
-8,61 млн
-8,70 млн
-10,51 млн
Net profit margin
-65,21%
-56,80%
-53,96%
-55,49%
Earnings per share
-0,37
-0,29
-0,26
-0,39
Interest and investment income
954,00 миң
1,03 млн
891,00 миң
839,00 миң
Interest expense
-380,00 миң
-330,00 миң
-311,00 миң
-313,00 миң
Net interest expenses
574,00 миң
698,00 миң
580,00 миң
526,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,95 млн
-9,22 млн
-9,18 млн
-10,91 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору